Navigation Links
Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
Date:1/9/2008

WASHINGTON, Jan. 9 /PRNewswire-USNewswire/ --- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the U.S. Health and Human Services Substance Abuse & Mental Health Services Association's National Survey on Drug Use and Health survey, which reported data on the prevalence of over-the-counter (OTC) cough medicine abuse among 12- to 25-year-olds in 2006:

"SAMHSA's annual study provides some valuable insight for parents and healthcare professionals to better understand teen behaviors, and we commend the survey authors for examining the troubling trend of young people abusing medicines to get high. The leading makers of OTC cough medicines are working tirelessly to raise awareness about cough medicine abuse and welcome these data to help inform adults about this dangerous behavior.

"These results --- as well as recent national survey results from the National Institute on Drug Abuse (NIDA)'s Monitoring the Future survey --- are evidence of the importance of the education efforts of many, including CHPA members.

"The nation's medicine makers are committed to providing educational programming about medicine abuse in the schools, at retail, within law enforcement, in the community, and online. And we've worked with lawmakers to advance legislation to prohibit the sale of the raw form of the active ingredient in cough medicines, dextromethorphan, to minors. But our job is far from over.

"CHPA and the makers of over-the-counter cough medicines remain dedicated to building on the successes of our multi-year educational campaign and are looking forward to the new programming 2008 will bring with our partners, including the Community Anti-Drug Coalitions of America, the Parent Teacher Association, the Partnership for a Drug-Free America, D.A.R.E. America, and the online Five Moms campaign.

"Our goal is to make sure parents are awar
'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 30, 2015 , ... On September 30, 2015, the ... of the 10 regionally accredited Maricopa Community Colleges , will be hosting a ... students pursuing employment information and opportunities. , The Expo has expanded to much more ...
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Dr. Tim ... mission. His mission is to increase acceptance of the chiropractic field in the ... that further debilitate them. Although Chiropractic was made available to the VA program ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES IN AMERICA, ... that it will be devoting an entire short segment to the subject of diabetes. ... the globe on a daily basis, but recent advancements in medical science may prove ...
Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... - Florida Upholds Contract Award To Orchid Cellmark For Multi-Year ... Paternity Testing - ... Work Underway In U.K. -, PRINCETON, N.J., July 31 Orchid Cellmark Inc.,(Nasdaq: ... financial results for the second quarter of,2008., Total revenues were $15.2 million for ...
... Offers Cost-Effective, Turnkey Digital Marketing for ... Targeted Lead Generation, ... now can market themselves directly to,America,s 31 million back pain sufferers ... LLC. The portal, http://www.backcarenetwork.com, harnesses the power of the internet ...
... Medical, Inc., a,privately held medical device company, announced today ... BMO Capital Markets 2008 Focus on,Healthcare conference on Tuesday, ... Hotel in New York City. Mr. Lien,s presentation will,include ... Details of the presentation follow: Date: ...
... launched a redesigned website that allows physicians and dentists to ... insurance plans. , ... San Clemente, ... http://www.doctordisability.com/ [disability insurance __title__ disability insurance] and life insurance ...
... hospital client King,s Daughters Medical Center (KDMC) in Brookhaven, ... as a part of the 2009 Health and Human ... the Senate Appropriations Committee earlier this month. KDMC,s grant ... (Miss.), was initiated by QHR and its strategic service ...
... is hosting a blood drive at its Phillipsburg location on Saturday, ... ... NJ (PRWEB) July 31, 2008 -- Phillipsburg Easton Honda is hosting ... from 11:00AM to 1:45PM., , , , ,"Demand for blood donations ...
Cached Medicine News:Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 8Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 9Health News:New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors 2Health News:New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors 3Health News:Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference 2Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 2Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 3Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 2Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 3Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 2Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 3
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ) ... on China,s Tobramycin Market, 2010-2019" report to their ... eye drop and ointment are the most common prescription ... caused by eye infection. Currently, dozens of enterprises in ... tobramycin, among which the Top 5 are s.a. Alcon- ...
(Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Quetiapine Market, ... Developed by AstraZeneca plc, quetiapine (under the trade ... the treatment of schizophrenia. Approved by CFDA to ... the Catalogue of Drugs for the Basic National ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sqh7xc/investigation ) ... on China,s Ranibizumab Market, 2012-2019" report to their ... by CFDA to treat wet age- related macular degeneration ... Novartis, is available in the Chinese market. However, in ... the treatment of wet AMD in China ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
... Cytogen,Corporation (NASDAQ: CYTO) reported updated data from ... (samarium Sm-153,lexidronam injection) in combination with bortezomib ... myeloma. Data from 33 patients were presented ... of Bortezomib (Vel) and Samarium,(Sam) in Multiple ...
... 100 percent response rate achieved with VELCADE, ... /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM) today ... clinical trials of VELCADE based,therapies that showed ... response(1) (CR) rates in newly diagnosed,multiple myeloma ...
Cached Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) IgA isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
Medicine Products: